Literature DB >> 18845958

Six-day randomized safety trial of intravaginal lime juice.

Christine K Mauck1, Susan A Ballagh, Mitchell D Creinin, Debra H Weiner, Gustavo F Doncel, Raina N Fichorova, Jill L Schwartz, Neelima Chandra, Marianne M Callahan.   

Abstract

OBJECTIVES: Nigerian women reportedly apply lime juice intravaginally to protect themselves against HIV. In vitro data suggest that lime juice is virucidal, but only at cytotoxic concentrations. This is the first controlled, randomized safety trial of lime juice applied to the human vagina.
METHODS: Forty-seven women were randomized to apply water or lime juice (25%, 50%, or undiluted) intravaginally twice daily for two 6-day intervals, separated by a 3-week washout period. Product application also was randomized: during 1 interval, product was applied using a saturated tampon and in the other by douche. Vaginal pH, symptoms, signs of irritation observed via naked eye examination and colposcopy, microflora, and markers of inflammation in cervicovaginal lavages were evaluated after 1 hour and on days 3 and 7.
RESULTS: The largest reduction in pH was about one-half a pH unit, seen 1 hour after douching with 100% lime juice. We observed a dose-dependent pattern of symptoms and clinical and laboratory findings that were consistent with a compromised vaginal barrier function.
CONCLUSIONS: The brief reduction in pH after vaginal lime juice application is unlikely to be virucidal in the presence of semen. Lime juice is unlikely to protect against HIV and may actually be harmful.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18845958     DOI: 10.1097/QAI.0b013e318186eae7

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  11 in total

Review 1.  Mechanisms and modifications of naturally occurring host defense peptides for anti-HIV microbicide development.

Authors:  Colleen R Eade; Matthew P Wood; Alexander M Cole
Journal:  Curr HIV Res       Date:  2012-01-01       Impact factor: 1.581

Review 2.  Non-specific microbicide product development: then and now.

Authors:  Joseph W Romano; Melissa Robbiani; Gustavo F Doncel; Thomas Moench
Journal:  Curr HIV Res       Date:  2012-01-01       Impact factor: 1.581

3.  Semen protects CD4+ target cells from HIV infection but promotes the preferential transmission of R5 tropic HIV.

Authors:  Emmanuel Balandya; Siddharth Sheth; Katherine Sanders; Wendy Wieland-Alter; Timothy Lahey
Journal:  J Immunol       Date:  2010-11-08       Impact factor: 5.422

4.  Female genital tract secretions inhibit herpes simplex virus infection: correlation with soluble mucosal immune mediators and impact of hormonal contraception.

Authors:  Gail F Shust; Sylvia Cho; Mimi Kim; Rebecca P Madan; Esmeralda M Guzman; Margaret Pollack; Julia Epstein; Hillel W Cohen; Marla J Keller; Betsy C Herold
Journal:  Am J Reprod Immunol       Date:  2009-12-15       Impact factor: 3.886

5.  Safety and anti-HIV assessments of natural vaginal cleansing products in an established topical microbicides in vitro testing algorithm.

Authors:  Carol S Lackman-Smith; Beth A Snyder; Katherine M Marotte; Mark C Osterling; Marie K Mankowski; Maureen Jones; Lourdes Nieves-Duran; Nicola Richardson-Harman; James E Cummins; Brigitte E Sanders-Beer
Journal:  AIDS Res Ther       Date:  2010-07-09       Impact factor: 2.250

6.  Clinical evidence for the role of Trichomonas vaginalis in regulation of secretory leukocyte protease inhibitor in the female genital tract.

Authors:  Jill S Huppert; Bin Huang; Chen Chen; Hassan Y Dawood; Raina N Fichorova
Journal:  J Infect Dis       Date:  2013-01-25       Impact factor: 5.226

7.  Homeostatic properties of Lactobacillus jensenii engineered as a live vaginal anti-HIV microbicide.

Authors:  Hidemi S Yamamoto; Qiang Xu; Raina N Fichorova
Journal:  BMC Microbiol       Date:  2013-01-08       Impact factor: 3.605

8.  Preclinical evaluation of lime juice as a topical microbicide candidate.

Authors:  Patricia S Fletcher; Sarah J Harman; Adrienne R Boothe; Gustavo F Doncel; Robin J Shattock
Journal:  Retrovirology       Date:  2008-01-11       Impact factor: 4.602

9.  Intravaginal practices and microbicide acceptability in Papua New Guinea: implications for HIV prevention in a moderate-prevalence setting.

Authors:  Andrew Vallely; Lisa Fitzgerald; Voletta Fiya; Herick Aeno; Angela Kelly; Joyce Sauk; Martha Kupul; James Neo; John Millan; Peter Siba; John M Kaldor
Journal:  BMC Res Notes       Date:  2012-11-01

10.  The Contribution of Cervicovaginal Infections to the Immunomodulatory Effects of Hormonal Contraception.

Authors:  Raina N Fichorova; Pai-Lien Chen; Charles S Morrison; Gustavo F Doncel; Kevin Mendonca; Cynthia Kwok; Tsungai Chipato; Robert Salata; Christine Mauck
Journal:  MBio       Date:  2015-09-01       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.